SCHEMBL23488692

SCHEMBL23488692

CC1O[C@H](CO)[C@@H](OC(=O)c2ccc(OCc3ccccc3)cc2)[C@H](O)[C@H]1O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 1/20 0.47
SELP P16109 8/20 0.47
LGALS9 O00182 3/20 0.47
LGALS1 P09382 3/20 0.47
LGALS3 P17931 3/20 0.47
LGALS7; LGALS7B P47929 2/20 0.47
NR4A1 P22736 1/20 0.46
NR4A2 P43354 1/20 0.46
NR4A3 Q92570 1/20 0.46
SELE P16581 2/20 0.45
PARP10 Q53GL7 1/20 0.44
SRD5A2 P31213 1/20 0.43
LGALS8 O00214 1/20 0.43
HIF1A Q16665 1/20 0.43
ALDH1A1 P00352 1/20 0.42
GAA P10253 1/20 0.42
MAPT P10636 1/20 0.42
HTT P42858 1/20 0.42
RAB9A P51151 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23488690 0.92 LGALS3 (0.55) MAOBSELPLGALS9LGALS1LGALS3
SCHEMBL23488416 0.92 LGALS9 (0.49) MAOBSELPLGALS9LGALS1LGALS3
SCHEMBL23488412 0.83 LGALS8 (0.53) MAOBSELPLGALS9LGALS1LGALS3
SCHEMBL23488417 0.83 LGALS8 (0.53) MAOBSELPLGALS9LGALS1LGALS3
SCHEMBL23488143 0.83 LGALS8 (0.53) MAOBSELPLGALS9LGALS1LGALS3
SCHEMBL23488305 0.81 MAOB (0.45) MAOBSELPLGALS9LGALS1LGALS3
SCHEMBL22490855 0.81 LGALS3 (0.50) MAOBLGALS9LGALS1LGALS3LGALS7; LGALS7B
SCHEMBL22490926 0.81 LGALS3 (0.50) MAOBLGALS9LGALS1LGALS3LGALS7; LGALS7B
SCHEMBL23488513 0.81 LGALS8 (0.64) MAOBLGALS9LGALS1LGALS3LGALS7; LGALS7B
SCHEMBL22490919 0.81 LGALS3 (0.50) MAOBLGALS9LGALS1LGALS3LGALS7; LGALS7B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210170033-A1 NOVEL CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN SANOFI (FR) 2021-06-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210170033-A1 NOVEL CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN GPR119, SLC2A8, SLC2A4 MAOB 4123/4885SELP 1001/4885LGALS9 106/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.